Tenaya Therapeutics, Inc. (TNYA)
0.6687
-0.03
(-4.10%)
USD |
NASDAQ |
Aug 24, 16:00
0.6687
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Shareholders Equity (Quarterly) : 69.41M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.41M |
| March 31, 2026 | 106.19M |
| December 31, 2025 | 123.26M |
| September 30, 2025 | 82.87M |
| June 30, 2025 | 99.83M |
| March 31, 2025 | 119.40M |
| December 31, 2024 | 92.85M |
| September 30, 2024 | 112.60M |
| June 30, 2024 | 134.00M |
| March 31, 2024 | 158.18M |
| December 31, 2023 | 139.42M |
| September 30, 2023 | 164.88M |
| Date | Value |
|---|---|
| June 30, 2023 | 189.94M |
| March 31, 2023 | 215.41M |
| December 31, 2022 | 243.38M |
| September 30, 2022 | 196.33M |
| June 30, 2022 | 223.87M |
| March 31, 2022 | 249.10M |
| December 31, 2021 | 278.53M |
| September 30, 2021 | 303.71M |
| June 30, 2021 | -108.52M |
| March 31, 2021 | -93.86M |
| December 31, 2020 | -81.23M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 727.71M |
| Anavex Life Sciences Corp. | 121.71M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.54M |
| Total Liabilities (Quarterly) | 24.13M |
| Debt to Equity Ratio | 0.0569 |
| Current Ratio | 4.522 |
| Net Debt Paydown Yield | 1.08% |